Drugs / Ropivacaine Hydrochloride Inj 2 mg/ml
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03332316 Background | Nov 2017 → Nov 2023 | — | Tampere University Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ropivacaine Hydrochloride Inj 2 mg/ml | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03332316 ↗ |